Copyright
©2006 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 21, 2006; 12(15): 2417-2422
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2417
Published online Apr 21, 2006. doi: 10.3748/wjg.v12.i15.2417
Pegylated IFN-α 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B
Themistoklis Vassiliadis, Konstantinos Tziomalos, Theodoros Gkiourtzis, Olga Giouleme, Nikolaos Grammatikos, Despoina Rizopoulou, Nikolaos Nikolaidis, Panagiotis Katsinelos, Nikolaos Eugenidis, 2nd Propaedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
Kalliopi Patsiaoura, Department of Pathology, Hippokration General Hospital, Thessaloniki, Greece
Eleni Orfanou-Koumerkeridou, 4th Department of Internal Medicine, Aristotle University of Thessaloniki, Hippokration General Hospital, Thessaloniki, Greece
Correspondence to: Konstantinos Tziomalos, 63 Solonos street, Thessaloniki, 54248, Greece. ktziomalos@yahoo.com
Telephone: +30-23-10823487 Fax: +30-23-10992834
Received: December 20, 2005
Revised: December 22, 2005
Accepted: January 14, 2006
Published online: April 21, 2006
Revised: December 22, 2005
Accepted: January 14, 2006
Published online: April 21, 2006
Core Tip